Key facts
- Digestive Disease Consultants Jacksonville’s last known valuation is $50.0M (Apr 2025).
- Notable investors include Eden Hall Capital.
- Status: Acquired/Merged (Operating Subsidiary).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Digestive Disease Consultants Jacksonville
- ·The full record, as it builds
Funding rounds
No funding rounds for Digestive Disease Consultants Jacksonville are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Digestive Disease Consultants Jacksonville
Provider of healthcare services designed for improving digestive wellness. The company offers advanced diagnostic procedures, treatments, capsule endoscopy, colonoscopy, hemorrhoid banding, esophageal manometry, and personalized care, enabling patients to achieve better gastrointestinal health outcomes.
- Sector
- Healthcare
- HQ
- Jacksonville, FL, United States
- Founded
- 2007
- Employees
- 168
- Website
- ddcjax.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Digestive Disease Consultants Jacksonville doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Digestive Disease Consultants Jacksonville shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Digestive Disease Consultants Jacksonville in its N-PORT filings yet. We sweep new filings monthly.